| Sarah Katelyn Johnson, LPN | |
|
240 Mitchell Bridge Rd, Athens, GA 30606-2043 | |
| (706) 389-6789 | |
| Not Available |
| Full Name | Sarah Katelyn Johnson |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 240 Mitchell Bridge Rd, Athens, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255190120 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | LPN099243 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Katelyn Johnson, LPN 61 Rolling Woods Ln, Hull, GA 30646-4093 Ph: (678) 672-0827 | Sarah Katelyn Johnson, LPN 240 Mitchell Bridge Rd, Athens, GA 30606-2043 Ph: (706) 389-6789 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to RiVax™ for the prevention of ricin intoxication. RiVax™ is a proprietary vaccine that contains a recombinant subunit of the A chain of ricin toxin which induces ricin neutralizing antibodies in humans and animals.
Even as the GOP flexes its new political muscle, news outlets offer analysis of the difficulties involved in the long-term strategy to prevent the health law's implementation — including the difficulties involved in attempts to defund it. Meanwhile, PBS explores how this debate could trigger the return of the "death panel" issue.
As the House Democratic leadership continues to work toward moving a health overhaul measure to the floor, members continue to stake out positions - sometimes because of their personal histories or where they are from. In a few cases, the positions they have taken lead to increased attention.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced the signature of an exclusive licence agreement with Novartis for the development, manufacture and commercialisation of Debio 025 (alisporivir), a selective, first-in-class cyclophilin (Cyp) inhibitor with a potent anti-hepatitis C virus (HCV) effect. The product is currently in phase 2b clinical development for the treatment of hepatitis C. Debiopharm granted Novartis worldwide commercialisation rights to Debio 025 except for Japan.
California's dirty air caused more than $193 million in hospital-based medical care from 2005 to 2007 as people sought help for problems such as asthma and pneumonia that are triggered by elevated pollution levels, according to a new RAND Corporation study.
› Verified 4 days ago
Pamela Brightwell, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 North Ave, Athens, GA 30601 Phone: 706-542-9700 Fax: 706-227-7249 | |
Ms. Debra Yvonne Hart, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 Bray St, Athens, GA 30601 Phone: 706-389-6789 | |
Olivia Bailey, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 240 Mitchell Bridge Rd, Athens, GA 30606 Phone: 706-369-4575 | |
Dorothy Campbell, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 North Ave, Athens, GA 30601 Phone: 706-389-6789 Fax: 706-227-7249 | |
Premal Callaway, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 North Ave, Athens, GA 30601 Phone: 706-389-6789 Fax: 706-227-7249 | |
Tamelia Ware, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 North Ave, Athens, GA 30601 Phone: 706-542-9700 Fax: 706-227-7249 | |
Yatemiese Smart, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 Bray St, Athens, GA 30601 Phone: 706-389-6789 |